119 related articles for article (PubMed ID: 18927094)
1. Early reporting for cancer screening trials.
Baker SG; Kramer BS; Prorok PC
J Med Screen; 2008; 15(3):122-9. PubMed ID: 18927094
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
4. The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials.
Li M; Zhang L; Charvat H; Callister ME; Sasieni P; Christodoulou E; Kaaks R; Johansson M; Carvalho AL; Vaccarella S; Robbins HA
Int J Cancer; 2022 Nov; 151(9):1491-1501. PubMed ID: 35809038
[TBL] [Abstract][Full Text] [Related]
5. Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.
Jodal HC; Løberg M; Holme Ø; Adami HO; Bretthauer M; Emilsson L; Ransohoff DF; Hoff G; Kalager M
Gastroenterology; 2018 Dec; 155(6):1787-1794.e3. PubMed ID: 30165051
[TBL] [Abstract][Full Text] [Related]
6. Population impact of lung cancer screening in the United States: Projections from a microsimulation model.
Criss SD; Sheehan DF; Palazzo L; Kong CY
PLoS Med; 2018 Feb; 15(2):e1002506. PubMed ID: 29415013
[TBL] [Abstract][Full Text] [Related]
7. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
8. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
[TBL] [Abstract][Full Text] [Related]
9. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
Swedish Organised Service Screening Evaluation Group
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
[TBL] [Abstract][Full Text] [Related]
10. Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations.
Patz EF; Swensen SJ; Herndon JE
J Clin Oncol; 2004 Jun; 22(11):2202-6. PubMed ID: 15169809
[TBL] [Abstract][Full Text] [Related]
11. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
12. Projecting the yearly mortality reductions due to a cancer screening programme.
Liu ZA; Hanley JA; Strumpf EC
J Med Screen; 2013; 20(3):157-64. PubMed ID: 24045921
[TBL] [Abstract][Full Text] [Related]
13. Screening for lung cancer: A systematic review and meta-analysis.
Usman Ali M; Miller J; Peirson L; Fitzpatrick-Lewis D; Kenny M; Sherifali D; Raina P
Prev Med; 2016 Aug; 89():301-314. PubMed ID: 27130532
[TBL] [Abstract][Full Text] [Related]
14. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
15. Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment.
Kubík AK; Parkin DM; Zatloukal P
Cancer; 2000 Dec; 89(11 Suppl):2363-8. PubMed ID: 11147613
[TBL] [Abstract][Full Text] [Related]
16. [Tuberculosis in Iceland. 1976].
Sigurdsson S
Laeknabladid; 2005 Jan; 91(1):69-102. PubMed ID: 16155306
[TBL] [Abstract][Full Text] [Related]
17. Improving the biomarker pipeline to develop and evaluate cancer screening tests.
Baker SG
J Natl Cancer Inst; 2009 Aug; 101(16):1116-9. PubMed ID: 19574417
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]